Page 1147 - Small Animal Internal Medicine, 6th Edition
P. 1147

CHAPTER 64   Encephalitis, Myelitis, and Meningitis   1119


            (complete blood count [CBC], chemistry including creatine   Bacterial cultures of the CSF and  blood are negative.  To
            kinase [CK] and urinalysis) and survey spinal radiographs   date, no etiologic agent has been identified.
  VetBooks.ir  are warranted in most cases. When these tests are negative,   alleviates the signs of fever and cervical pain. Dogs not
                                                                   Treatment with glucocorticoids consistently and rapidly
            advanced imaging (computed tomography [CT], magnetic
            resonance imaging [MRI]), and synovial fluid and CSF col-
                                                                 neurologic deficits associated with spinal cord infarction and
            lection and analysis are usually recommended.        treated early in the course of the disease occasionally develop
                                                                 meningeal fibrosis; treatment may not resolve the resultant
                                                                 neurologic signs in these dogs. Glucocorticoids should be
            NONINFECTIOUS INFLAMMATORY                           administered initially at immunosuppressive dosages and
            DISORDERS                                            then tapered to alternate-day therapy and decreasing dosages
                                                                 over a period of 4 to 6 months (Box 64.2). Dogs that do not
            STEROID-RESPONSIVE                                   respond completely to prednisone and dogs that relapse
            MENINGITIS-ARTERITIS                                 during prednisone tapering may benefit from the addition
            SRMA is one of the most common forms of meningitis diag-  of oral (PO) azathioprine (Imuran [Burroughs Wellcome],
            nosed in most veterinary hospitals. An immunologic cause is   2.2 mg/kg PO q24h) to their treatment for 8 to 16 weeks. The
            suspected, resulting in vasculitis/arteritis affecting the men-  prognosis for survival and complete resolution is excellent,
            ingeal vessels throughout the entire length of the spinal cord   with 60% to 80% of dogs with acute signs recovering with
            and brainstem. This disorder has also been called  aseptic   treatment and never relapsing. Older dogs and Beagles,
            meningitis, steroid-responsive suppurative meningitis, necro-  Bernese Mountain dogs, Nova Scotia Duck Tolling Retriev-
            tizing vasculitis, juvenile polyarteritis, and Beagle pain syn-  ers, and German Shorthaired Pointers with breed-associated
            drome. Affected dogs are usually juveniles or young adults   SRMA may have disease that is more difficult to control, so
            (6-18 months of age), but middle-aged and older dogs are   treatment with prednisone and azathioprine from the outset
            occasionally affected. Large-breed dogs are most commonly   and a more prolonged schedule for tapering of prednisone
            affected. SRMA may be seen as a breed-associated syndrome   dose may be warranted. Lifelong treatment is rarely required.
            in Beagles, Bernese Mountain dogs, Boxers, German Short-
            haired Pointers, Bassett Hounds, and Nova Scotia Duck   CANINE MENINGOENCEPHALITIS OF
            Tolling Retrievers.                                  UNKNOWN ETIOLOGY
              Clinical signs of SRMA include fever (50%-90%), reluc-  Nonsuppurative meningoencephalitis of unknown cause is a
            tance to move, neck pain, and vertebral pain that may wax   frequent finding in dogs. Unsuccessful systematic efforts to
            and wane early in the course of disease. Affected dogs are   identify infectious causes, particularly viral and protozoal
            alert and systemically normal, with a common owner com-  agents, have resulted in the conclusion that these disorders
            plaint being that the dog will not eat or drink unless the   are likely to have an immune-mediated or hereditary patho-
            bowl is raised to head level. Neurologic deficits (e.g., paresis,   genesis. Although attempts are made to differentiate three
            paralysis, ataxia) are very uncommon but can develop in   distinct disorders—granulomatous meningoencephalitis
            chronically affected or inadequately treated dogs as a result   (GME), necrotizing meningoencephalitis (NME), and nec-
            of concurrent myelitis, spinal cord hemorrhage, or infarc-  rotizing leukoencephalitis (NLE)—based on clinical and
            tion.  Signs  of  intracranial  extension  of  inflammation  are   laboratory features, imaging characteristics, and breed pre-
            rare. The vast majority of dogs with SRMA are presented   disposition, a definitive diagnosis cannot be obtained without
            for neck pain and fever but have a normal neurologic
            examination.
              Laboratory changes typically include a neutrophilic leu-
            kocytosis with or without a left shift. Hypoalbuminemia and    BOX 64.2
            hyperglobulinemia suggest systemic  inflammation. Cervi-  Treatment Recommendations for Steroid-Responsive
            cal radiographs are often performed to look for evidence of   Meningitis Arteritis
            diskospondylitis and are normal. Spinal fluid analysis shows
            a neutrophilic pleocytosis (often >100 cells/µL; >75% neu-  1. Prednisone 2 mg/kg q12h orally for 2 days
            trophils) and an increased protein concentration. Early in   2. Prednisone 2 mg/kg q24h orally for 14 days
            the course of the disease, when neck pain is  intermittent,   3. Assess clinical response.
            CSF may be normal or minimally inflammatory. Within 24   If clinical signs have resolved, the dose of prednisone
            hours of administration of a single dose of prednisone, CSF   is gradually tapered:
            may  be  normal  or  show  a  predominance  of  mononuclear   1 mg/kg q24h for 4-6 weeks
            cells; therefore CSF should always be collected for diagnosis   1 mg/kg q48h for 4-6 weeks
                                                                  0.5 mg/kg q48h for 8 weeks
            when a dog is symptomatic before initiating therapy. High   If clinical signs are present or if they recur during taper-
            immunoglobulin (Ig)A concentrations are found in the CSF   ing, return to step 2 and add azathioprine (2 mg/kg/day)
            and serum of most dogs (>90%) with SRMA, aiding diagno-  to treatment for 8-16 weeks. Continue prednisone, tapering
            sis, but this finding lacks specificity. Some dogs with SRMA   after signs resolve.
            have concurrent immune-mediated polyarthritis  (IMPA).
   1142   1143   1144   1145   1146   1147   1148   1149   1150   1151   1152